Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Phase I Study to Assess the Safety and Immunogenicity of ChAd63 ME-TRAP - MVA ME-TRAP Heterologous Prime-boost Vaccination Co-administered With EPI Vaccines in Gambian Infants (VAC058)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02083887
Recruitment Status : Completed
First Posted : March 11, 2014
Last Update Posted : December 3, 2015
Malaria Vectored Vaccines Consortium
Information provided by (Responsible Party):
University of Oxford